CrossrefInfokarte
Na-dependent glucose transporter-2 inhibitors, bone mineral density, and fracture risk in type-2 diabetes mellitus with osteoporosis: A meta-analysis of 2,000 patients
Int. Journal of Clinical Pharmacology and Therapeutics · 2026-09-10
DOI: 10.5414/cp204936 ↗Abstract
Kein Abstract verfügbar.
EUVIMED